Form 4: CME Group Director Bryan T. Durkin Reports Acquisition of Common Stock

Bryan T. Durkin, a director at CME Group Inc., reported acquiring 748 shares of Class A Common Stock at a price of $194.1 on June 25, 2024, bringing his total holdings to 63,200 shares.

Summary

• On June 25, 2024, Bryan T. Durkin, a director of CME Group Inc., acquired 748 shares of Class A Common Stock.
• The acquisition price was $194.1 per share.
• This transaction increased Durkin's direct ownership to 63,200 shares.
• The shares were granted pursuant to the CME Group Director Stock Plan, as amended and restated.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a stock transaction by a company director. The increased ownership could be seen as slightly positive, but it's not a major event.

Positives

• The director's increased stake in the company could be seen as a positive signal.

Industry Context

This filing is a routine disclosure of a director's stock transaction, which is common in publicly traded companies. It provides transparency to investors regarding the holdings and transactions of company insiders.

Comparison to Industry Standards

• Director stock ownership is a common practice in publicly listed companies like CME Group.
• Comparing Durkin's holdings and transactions to those of directors at similar companies such as Intercontinental Exchange (ICE) or Nasdaq, Inc. (NDAQ) could provide a benchmark for assessing the significance of his stake.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency to shareholders regarding director stock ownership.

Key Dates